Ipca Laboratories Ltd. — Capital/Financing Update 2025

Jul 7, 2025

==> picture [105 x 47] intentionally omitted <==

THRU ONLINE FILING

July 7, 2025

BSE Ltd. National Stock Exchange India Limited, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block-G, Dalal Street Bandra Kurla Complex, Bandra – (East). Mumbai 400 023 Mumbai-400051. Scrip Code – 524494 Scrip Code : IPCALAB

Sub: Credit Rating for bank facilities and commercial paper

This is to inform you that India Ratings & Research (A Fitch Group Company) has reviewed and affirmed the following ratings to Company’s working capital limit, long term loan and commercial paper:

Instrument Type	MaturityDate	Size of Issue(Million)	Rating AssignedalongwithOutlook/Watch	RatingAction
CommercialPaper*#		INR 500	IND A1+	Affirmed
Fund/Non-fundbased workingcapital limit		INR 20,150	IND AA+/ Stable /IND A1+	Affirmed
Long-term loan	27.03.2028	INR 3787.3(reduced fromINR 5185.6)	IND AA+/Stable	Affirmed
Proposed long-term loan	-	INR 2,000	IND AA+/Stable	Affirmed

*The CP is not carved out of Ipca’s fund-based working capital limits.

This is for your information and record.

Thanking you

Yours faithfully For Ipca Laboratories Limited Digitally signed by Harish Pandurang Kamath Harish DN: c=IN, o=Personal, title=1715, pseudonym=585f434c9c014c338904fe5f4cd8762 a, 2.5.4.20=955479ec580ea690ffd8de8b74071cf6f1e e247da687a7ae82030a7ae82c443b, Pandurang postalCode=400063, st=Maharashtra, serialNumber=72050fb9fadcbc5de6404685117b8 355792f5784c7617d9c4cae2a3887d6b809, Kamath cn=Harish Pandurang Kamath Date: 2025.07.07 18:18:47 +05'30' Harish P. Kamath Corporate Counsel & Company Secretary

==> picture [445 x 70] intentionally omitted <==